Table 1.
Mean ± SEM | Drug | Placebo (n=31) | |
---|---|---|---|
Liraglutide (n=18) | Exenatide (n=10) | ||
Gender (% Female) | 89 % | 60 % | 80.6 % |
Age (years) | 41.4 ± 2.6 | 39.0 ± 3.6 | 38.4 ± 2.2 |
Baseline BMI (Kg/m2) | 37.4 ± 1.0 | 34.6 ± 0.9 | 35.7 ±0.7 |
Mean ± SEM | Drug | Placebo (n=31) | |
---|---|---|---|
Liraglutide (n=18) | Exenatide (n=10) | ||
Gender (% Female) | 89 % | 60 % | 80.6 % |
Age (years) | 41.4 ± 2.6 | 39.0 ± 3.6 | 38.4 ± 2.2 |
Baseline BMI (Kg/m2) | 37.4 ± 1.0 | 34.6 ± 0.9 | 35.7 ±0.7 |